US Drug Recall Register
Class III · Low risk Terminated Initiated Oct 11, 2019 (7 years ago)

Levetiracetam Injection

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached.

What was recalled

Levetiracetam Injection, 500 mg/5mL, 10 single-use 5 mL vials, Rx only, Manufactured by: Agile Specialties Private Limited Pilot No. 14, Sipcot II, Hosur-635 109 Tamil Nadu, India, Manufactured for: X-Gen Pharmaceuticals, Inc. Big Flats, NY 14814, NDC 39822-4000-1

Recalling firm
X-Gen Pharmaceuticals Inc.
NDC code
39822-4000-1
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0519-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Levetiracetam recalls

See all
Class I · High risk Ongoing

Levetiracetam 0.75% in Sodium Chloride Injection 1

Reason LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.

Dr. Reddy's Laboratories, Inc. NDC 43598-636-52 D-0365-2025
Class II · Moderate risk Ongoing

Levetiracetam Oral Solution 100 mg/mL

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0816-2023
Class III · Low risk Terminated

Levetiracetam Tablets USP

Reason Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam

McKesson Corporation dba McKesson Drug Company NDC 63739-795-10 D-0630-2021
Class II · Moderate risk Terminated

Levetiracetam Oral Solution

Reason Defective container: Customer complaints for oral solution leaking from bottles.

Akorn, Inc. NDC 50383-241-16 D-0221-2021
Class II · Moderate risk Terminated

Levetiracetam Tablets

Reason Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.

Eywa Pharma INC NDC 71930-063-52 D-0109-2021